FDAnews Drug Daily Bulletin

CADENCE COMPLETES ACQUISITION OF INTRAVENOUS ACETAMINOPHEN RIGHTS

March 31, 2006
A A

Cadence Pharmaceuticals Inc. announced Thursday that it has completed its acquisition of the rights to an intravenous formulation of acetaminophen, IV APAP.

San Diego Source (http://www.sddt.com/News/article.cfm?SourceCode=20060330tqc)